Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Necrosis01:16

Necrosis

4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 铁作为三阴性乳腺癌的治疗途径:机制性见解和预后潜力

铁作为三阴性乳腺癌的治疗途径:机制性见解和预后潜力

Taimoor Riaz1, Muhammad Ali Saleem1, Muhammad Umar Muzafar Khan1

  • 1Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad 38000, Pakistan.

Biomedicines
|August 28, 2025

相关实验视频

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.1K
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

在PubMed 上查看摘要

概括
此摘要是机器生成的。

三重阴性乳腺癌 (TNBC) 是一种侵袭性疾病, 干扰素马 (IFNG) 是一个关键的调节剂,作为预后生物标志物和治疗点,以改善结果.

科学领域:

  • 癌症学
  • 分子生物学
  • 遗传学

背景情况:

  • 三重阴性乳腺癌 (TNBC) 具有攻击性,预后不佳.
  • 铁,一种依赖于铁的细胞死亡,在TNBC中具有治疗脆弱性.
  • 鉴定TNBC中铁衰的关键调节剂对于开发新疗法至关重要.

研究的目的:

  • 描述TNBC与铁相关的分子结构.
  • 在TNBC中确定具有预后和转化意义的关键调节基因.
  • 探索针对TNBC治疗的铁性途径的潜力.

主要方法:

  • 来自TNBC和正常乳腺组织样本的转录形状分析.
  • 识别与铁相关的差异表达基因 (DEG).
  • 构建蛋白质与蛋白质相互作用网络和功能丰富分析 (GO,KEGG,Reactome).
  • 使用生存分析评估预后相关性.

主要成果:

  • 确定了六种铁死驱动剂和五种抑制剂,以及一种双功能调节剂 (HMOX1).
  • 丰富分析显示与氧化应激,自,免疫调节和瘤进展有关.
  • 高的干扰素马 (IFNG) 表达与改善的存活率相关,并且在抗瘤免疫和铁死敏感化方面表现出双重功能.
关键词:
其他国家生物信息学分析基因表达分析精密瘤学

相关实验视频

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.1K
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

结论:

  • 铁是TNBC的一个关键途径.
  • 干扰素玛 (IFNG) 是一个有前途的预后生物标志物和TNBC的治疗点.
  • 与免疫疗法结合的向铁症可能会改善TNBC患者的临床结果.
预后生物标志物
翻译研究